Searched for: school:SOM
Department/Unit:Cell Biology
A molecular brake in the kinase hinge region regulates the activity of receptor tyrosine kinases
Chen, Huaibin; Ma, Jinghong; Li, Wanqing; Eliseenkova, Anna V; Xu, Chongfeng; Neubert, Thomas A; Miller, W Todd; Mohammadi, Moosa
Activating mutations in the tyrosine kinase domain of receptor tyrosine kinases (RTKs) cause cancer and skeletal disorders. Comparison of the crystal structures of unphosphorylated and phosphorylated wild-type FGFR2 kinase domains with those of seven unphosphorylated pathogenic mutants reveals an autoinhibitory 'molecular brake' mediated by a triad of residues in the kinase hinge region of all FGFRs. Structural analysis shows that many other RTKs, including PDGFRs, VEGFRs, KIT, CSF1R, FLT3, TEK, and TIE, are also subject to regulation by this brake. Pathogenic mutations activate FGFRs and other RTKs by disengaging the brake either directly or indirectly
PMCID:2094128
PMID: 17803937
ISSN: 1097-2765
CID: 73939
LeuT-Desipramine Structure Reveals How Antidepressants Block Neurotransmitter Reuptake
Zhou, Zheng; Zhen, Juan; Karpowich, Nathan K; Goetz, Regina M; Law, Christopher J; Reith, Maarten E A; Wang, Da-Neng
Tricyclic antidepressants exert their pharmacological effect-inhibiting the reuptake of serotonin, norepinephrine, and dopamine-by directly blocking neurotransmitter transporters (SERT, NET, and DAT, respectively) in the presynaptic membrane. The drug-binding site and the mechanism of this inhibition are poorly understood. We determined the crystal structure at 2.9 A of the bacterial leucine transporter (LeuT), a homolog of SERT, NET, and DAT, in complex with leucine and the antidepressant desipramine. Desipramine binds at the inner end of the extracellular cavity of the transporter and is held in place by a hairpin loop and by a salt bridge. This binding site is separated from the leucine-binding site by the extracellular gate of the transporter. By directly locking the gate, desipramine prevents conformational changes and blocks substrate transport. Mutagenesis experiments on human SERT and DAT indicate that both the desipramine-binding site and its inhibition mechanism are probably conserved in the human neurotransmitter transporters
PMCID:3711652
PMID: 17690258
ISSN: 1095-9203
CID: 73794
RbAp48 is a critical mediator controlling the transforming activity of human papillomavirus type 16 in cervical cancer
Kong, Li; Yu, Xiu-Ping; Bai, Xiao-Hui; Zhang, Wei-Fang; Zhang, Yan; Zhao, Wei-Ming; Jia, Ji-Hui; Tang, Wei; Zhou, Ya-Bin; Liu, Chuan-ju
Although human papillomavirus (HPV) infections are the primary cause of cervical cancer, the molecular mechanism by which HPV induces cervical cancer remains largely unclear. We used two-dimensional electrophoresis with mass spectrometry to study protein expression profiling between HPV16-positive cervical mucosa epithelial H8 cells and cervical cancer Caski cells to identify 18 differentially expressed proteins. Among them, retinoblastoma-binding protein 4 (RbAp48) was selected and its differentiation expression verified with both additional cervical cancer-derived cell lines and human tissues of cervical intraepithelial neoplasia and cervical cancer. Suppression of RbAp48 using siRNA approach in H8 cells significantly stimulated cell proliferation and colony formation and inhibited senescence-like phenotype. Remarkably, H8 cells acquired transforming activity if RpAp48 was suppressed, since H8 cells stably transfected with RbAp48 siRNA led to tumor formation in nude mice. In addition, overexpression of RbAp48 significantly inhibited cell growth and tumor formation. This RbAp48-mediated transformation of HPV16 is probably due to the regulation by RbAp48 of tumor suppressors Rb and p53, apoptosis-related enzymes caspase-3 and caspase-8, and oncogenic genes, including cyclin D1 and c-myc. In brief, RbAp48, previously unknown in cervical carcinogenesis, was isolated in a global screen and identified as a critical mediator controlling the transforming activity of HPV16 in cervical cancer
PMID: 17616526
ISSN: 0021-9258
CID: 73350
Pancreaticoureteral fistula following penetrating abdominal trauma [Case Report]
Wolf, Joshua H; Miller, George; Ashinoff, Russell; Dave, Jasmine; Lefleur, Richard S; Frangos, Spiros G; Miglietta, Maurizio A
CONTEXT: The main pancreatic duct can form a fistulous communication with another epithelium in the setting of prolonged inflammation, operative manipulation, or direct trauma. We present a rare complication of a pancreaticoureteral fistula following a trauma nephrectomy. CASE REPORT: A 17-year-old male who sustained a gunshot wound to the back arrived to our Emergency Room hyopotensive, tachycardic, and with free intraperitoneal fluid on focused assessment sonography for trauma (FAST) exam. He was taken to the operating room for an exploratory laporatomy where a left nephrectomy was performed to control active bleeding from the left renal hilum. Significant bleeding was also encountered at the portal venous confluence. After packing and damage control laparotomy, the periportal/pancreatic bleeding was controlled during a second procedure 6 hours later. After one month in the Intensive Care Unit with an open abdomen, a computed tomography (CT) scan revealed a fluid collection in the splenic fossa which was drained by catheter. Persistent drainage revealed a high amylase concentration (greater than 50,000 U/L). A fistulogram revealed interruption of the main pancreatic duct, and a fluid collection by the tail of the pancreas that was in communication with the left ureter. The patient's urine amylase was also elevated. The patient was treated non-operatively given the healing open abdomen and controlled fistula. He had an otherwise uncomplicated recovery. CONCLUSIONS: This is the second report of a pancreaticoureteral fistula in the literature. Treatment of this communication should be similar to that of other pancreatic fistulae
PMID: 17873469
ISSN: 1590-8577
CID: 74304
Loss of annexin VI affects endochondral bone formation [Meeting Abstract]
Kim, H; Moss, SE; Kirsch, T
ISI:000250509101352
ISSN: 0884-0431
CID: 83090
Progressive ankylosis gene (ank) regulates osteoblast differentiation [Meeting Abstract]
Kirsch, T; Kim, H; Winkles, JA
ISI:000250509100340
ISSN: 0884-0431
CID: 83089
IFI16 inhibits tumorigenicity and cell proliferation of bone and cartilage tumor cells
Zhang, Yan; Howell, Ronald D; Alfonso, Daniel T; Yu, Jin; Kong, Li; Wittig, James C; Liu, Chuan-ju
IFI16 is a member of the interferon-inducible p200-protein family, capable of modulating cell proliferation, and cellular senescence. In this study, these effects of IFI16 were studied in tumor cells derived from bone and cartilage. The level of IFI16 was markedly lower in human osteosarcomas as compared with its level in normal bone. Overexpression of functional IFI16 in human osteosarcoma and chondrosarcoma cell lines markedly inhibited colony formation, and significantly inhibited cell growth, an effect that could be reversed by introduction of gene specific siRNA into tumor cells. These inhibitory effects of IFI16 were associated with upregulation of p21 and inhibition of cyclin E, cyclin D1, c-Myc and Ras. In addition, ectopic expression of IFI16 in tumor cells increased senescence-associated beta-galactosidase and induced a senescence-like phenotype. In view of such effects, IFI16 might be a suitable target for therapeutic intervention in osteosarcoma and chondrosarcoma.
PMID: 17569615
ISSN: 1093-9946
CID: 72852
In vivo role of NAD(P)H:quinone oxidoreductase 1 in metabolic activation of mitomycin C and bone marrow cytotoxicity
Adikesavan, Anbu Karani; Barrios, Roberto; Jaiswal, Anil K
NAD(P)H:quinone oxidoreductase 1(-/-) (NQO1(-/-)), NQO1(+/-) along with NRH:quinone oxidoreductase 2(-/-) (NQO2(-/-)), and wild-type (WT) mice were exposed to five once weekly doses of mitomycin C. The mice were euthanized 15 weeks after the first dose. Blood cell counts and histologic analyses were done. WT and NQO2(-/-) mice showed hypocellularity and a significant increase in adipocytes in bone marrow. They also showed anemia because of the loss of RBC and hemoglobin. The neutrophils and platelets were reduced, whereas other blood cell types and tissues were normal. Interestingly, NQO1(-/-) mice showed a complete resistance to mitomycin C-induced bone marrow cytotoxicity and reduction in RBC, hemoglobin, and neutrophils. NQO1(+/-) mice also showed limited resistance to mitomycin C-induced bone marrow cytotoxicity. These data show a major in vivo role of NQO1 in metabolic activation of mitomycin C with implications in mitomycin C chemotherapy.
PMID: 17804703
ISSN: 0008-5472
CID: 989282
Does melanin have an SPF and can it be measured? [Meeting Abstract]
Epstein, H; Manga, P; Koshoffer, A; Story, D; Simion, T; Boissy, R
ISI:000253000700027
ISSN: 1525-7886
CID: 87151
ECM1, a direct targeting molecule of PTHrP, is a novel potent mediator of chondrogenesis [Meeting Abstract]
Kong, L; Zhang, Y; Jiang, B; Xie, Y; Feng, JO; Kobayashi, T; Kronenberg, HM; Liu, C
ISI:000250509100063
ISSN: 0884-0431
CID: 98151